NCT02173288View on ClinicalTrials.gov

Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
CirrhosisRefractory/Recurrent Ascites
Interventions
DRUG

Standard medical therapy

DRUG

Tolvaptan

DRUG

Midodrine

Trial Locations (1)

160012

Dept. of Hepatology, PGIMER, Chandigarh, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT02173288 - Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites | Biotech Hunter | Biotech Hunter